Timothy Hoey - SVP, Oncomed Pharmaceuticals Inc

As of April 25, 2017


Timothy Hoey Net Worth

  • Net worth is estimated to be at least $1.18M
  • Owns at least 57,225 units of Oncomed Pharmaceuticals Inc stock
  • Sold an estimated value of $1.05M in the last 4 years at Oncomed Pharmaceuticals Inc

Timothy Hoey Trading

  • Largest purchase of shares was 12,763 units , worth over $18.25K on January 5, 2017
  • Largest sale of shares was 6,887 units , worth over $176.64K on April 29, 2015
  • In total has made about 18 transactions over 4 years
  • Usually trades in April, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Timothy Hoey Mailing Address

  • Mailing address is C/o Tenaya Therapeutics, Inc. 171 Oyster Point Boulevard, 5th Flr. South San Francisco CA 94080 CA

Oncomed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Total
John A. Lewicki, Ph.D., 2017 $419,777 $192,925 $967,675 $167,911 $1,748,288
John A. Lewicki, Ph.D., 2016 $407,550 $141,750 - $146,718 $696,018
Paul Hastings, 2017 $551,127 $169,650 $1,857,110 $60,624 $2,638,511
Paul Hastings, 2016 $535,075 $158,760 - $264,862 $958,697
Sunil Patel, 2017 $406,117 $183,600 $939,700 $167,780 $1,697,197
Austin Gurney, Ph.D., 2017 $365,612 $154,536 $804,964 $116,996 $1,442,108
Alicia Hager, J.D., Ph.D., 2017 $347,619 $154,536 $804,964 $125,143 $1,432,262
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1302573/000156459018009577/omed-def14a_20180622.htm

Oncomed Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 11,117 units sold on December 26, 2018 by Austin Gurney worth over $6.67K
  • In the last 5 years, insiders at Oncomed Pharmaceuticals Inc sold an estimated value of $14.76M and bought an estimated value of $23.88M
  • The most active traders are Austin Gurney, See Remarks,  John A Lewicki, President and CEO,  and Alicia J Hager, SVP and General Counsel
  • Insider trading is most common in June, with the busiest year in 2015

OncoMed Pharmaceuticals Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1